Kürzel | Analyse | Material | |
---|---|---|---|
TX1 | TX1 Bäume Mix 1 | MATERIAL: Serum, METHODE: LIA | |
TX2 | TX2 Bäume (Spätbl.) | MATERIAL: Serum, METHODE: LIA | |
TX5 | TX5 Bäume (Frühbl.) | MATERIAL: Serum, METHODE: LIA | |
TX6 | TX6 Bäume (Spätbl.) | MATERIAL: Serum, METHODE: LIA | |
TX9 | TX9 Bäume Mix 9 | MATERIAL: Serum, METHODE: LIA | |
TZ | Thrombinzeit | MATERIAL: Citrat, | |
UBG | Urobilinogen | MATERIAL: Spontanharn, METHODE: STIX | |
UBI | Ubichinon (Coenzym Q10) | MATERIAL: EDTA-Blut; METHODE: HPLC | |
UBILIPKOR | Ubichinon lipidkorrigiert | MATERIAL: Serum (gefroren) METHODE: HPLC | |
VAL | Valproinsäure | MATERIAL: Serum/Vollblut, METHODE: FPIA | |
VANADKR | Vanadium /g Krea i.H. | MATERIAL: Spontanharn, METHODE: | |
VANADKR_AM | Vanadium /g Krea i.H. (expon.) | MATERIAL: Spontanharn, METHODE:berechnet | |
VANADU | Vanadium i.H. | MATERIAL: Spontanharn, METHODE: ICP-MS | |
VANCO | Vancomycin | MATERIAL: Serum/Vollblut; METHODE: FPIA | |
VCA | Virus capsid antigen | ||
VDRL | RPR/VDRL qualitativ | MATERIAL: Serum/Vollblut, METHODE: Agglutination | |
VDRLquant | RPR/VDRL quantitativ | MATERIAL: Serum/Vollblut, METHODE: | |
VEDOLIZU | Vedolizumab Monitoring | MATERIAL: Serum gefroren | |
VEDOLIZUAK | Vedolizumab-AK (Entyvio) | MATERIAL: Serum gefroren | |
VENLA | Venlafaxin | MATERIAL: Serum/Vollblut METHODE: LC-MS |